ZyVersa Therapeutics Balance Sheet Health
Financial Health criteria checks 3/6
ZyVersa Therapeutics has a total shareholder equity of $11.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $22.1M and $11.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.14m |
| Equity | US$11.07m |
| Total liabilities | US$11.04m |
| Total assets | US$22.11m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ZVSA's short term assets ($3.4M) do not cover its short term liabilities ($10.2M).
Long Term Liabilities: ZVSA's short term assets ($3.4M) exceed its long term liabilities ($844.9K).
Debt to Equity History and Analysis
Debt Level: ZVSA is debt free.
Reducing Debt: ZVSA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ZVSA has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ZVSA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 36% each year